Endogenous thrombin potential (ETP) in pleural effusions

L. Teixeira, M. Colombini, F. Vargas, M. Acencio, R. Siqueira, C. Silva, V. Alvarenga, L. Antonangelo (São Paulo, Brazil)

Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Session: Molecular markers: diagnosis and management of malignant pleural effusions
Session type: Poster Discussion
Number: 3545
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Teixeira, M. Colombini, F. Vargas, M. Acencio, R. Siqueira, C. Silva, V. Alvarenga, L. Antonangelo (São Paulo, Brazil). Endogenous thrombin potential (ETP) in pleural effusions. Eur Respir J 2011; 38: Suppl. 55, 3545

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006

Intrapleural fibrinolysis modulation in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 517s
Year: 2001

Effectiveness and safety of tissue plasminogen activators (t-PA) in complicated pleural effusion (CPE), what the correlation with time it stays in the pleural space?
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013


The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE)
Source: Eur Respir J 2002; 20: Suppl. 38, 70s
Year: 2002

Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE)
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001

Measurement of pleural fluid lactate dehydrogenase and adenosine deaminase for distinguishing malignant pleural effusions and other exudative pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004

Diagnostic implications of telomerase activity in pleural effusions
Source: Eur Respir J 2003; 22: 422-426
Year: 2003



Role of adenosine deaminase (ADA) in differentiating tuberculous pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 644s
Year: 2004

Role of pleural irrigation with normal saline versus streptokinase in complicated pleural effusions.
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019


Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007



Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE)
Source: Eur Respir J 2007; 30: Suppl. 51, 103s
Year: 2007

Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010


Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

Interleukin-16 in tuberculous and malignant pleural effusions
Source: Eur Respir J 2005; 25: 605-611
Year: 2005



Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009

Pleural NT-PROBNP and albumin gradient (serum-pleural levels difference) in patients with exudative pleural effusion (PE) and previous diuretic therapy
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Utility of significant number of mesothelial cells in tuberculous pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 426s
Year: 2004

Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012